AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2020
Sep 9, 2020
30786_dirs_2020-09-09_df932b3e-51d1-4336-8a69-f9db89c4a98b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-09-04
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-04 | Bio-Rad A Common Stock | M | 2600 | — | Acquired | 418951 | Direct |
| 2020-09-04 | Bio-Rad A Common Stock | F | 1290 | $484.23 | Disposed | 417661 | Direct |
| 2020-09-05 | Bio-Rad A Common Stock | M | 2600 | — | Acquired | 420261 | Direct |
| 2020-09-05 | Bio-Rad A Common Stock | F | 1290 | $484.23 | Disposed | 418971 | Direct |
| 2020-09-07 | Bio-Rad B Common Stock | M | 3000 | — | Acquired | 298122 | Direct |
| 2020-09-07 | Bio-Rad B Common Stock | F | 1488 | $480.2 | Disposed | 296634 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-09-04 | Restricted Stock Units | $0 | M | 2600 | Disposed | Bio-Rad A Common Stock (2600) | Direct | |
| 2020-09-05 | Restricted Stock Units | $0 | M | 2600 | Disposed | Bio-Rad A Common Stock (2600) | Direct | |
| 2020-09-07 | Restricted Stock Units | $0 | M | 3000 | Disposed | Bio-Rad B Common Stock (3000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad B Common Stock | 12811 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Shares of Class B common stock acquired on the vesting of restricted stock units.
F3: The reporting person disclaims beneficial ownership of these shares.
F4: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F6: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.
F7: The restricted stock units vest in five equal annual installments beginning September 4, 2019.
F8: The restricted stock units vest in five equal annual installments beginning September 5, 2018.
F9: The restricted stock units vest in five equal annual installments beginning September 7, 2017.